The most common presenting symptoms and signs in patients with synchronous primary endometrial and ovarian cancers, are: abnormal uterine bleeding (46%), abdominal/pelvic pain (17%) and abdominal/ pelvic mass (13%) [1, 2, 9, 11, 13, 15, 16, 25] .
Synchronous primary endometrial and ovarian cancers may have similar or different histologic appearance [6, 10, 14] . The distinction between metastatic and synchronous primary cancers is relatively easy, when they have different histologic types [26, 27] However the distinction is relatively difficult, when they have the same histologic type [26, 27] . For those patients in clinical practise we use well described empirical criteria [26, 27] .
The treatment of choice for most patients with synchronous primary endometrial and ovarian cancers, is systematic surgical staging [1-4 ,6,11,12,14,15,28-30] . More specifically in those patients, systematic surgical staging includes: total abdominal hysterectomy with bilateral salpingo-oophorectomy, total omentectomy, appendectomy, pelvic and para-aortic lymphadenectomy, complete resection of all disease, biopsy of any suspected lesion and pelvic washings [1, 4, 6, 11, 12, 14, [28] [29] [30] [31] [32] .
That therapeutic approach allows a more clear decision for stage related postoperative adjuvant treatment [1, 2, 29, 30] . Moreover, appropriate surgical staging facilitates targeted therapy that maximize survival and minimize the morbidity of overtreatment (radiation injury, chemotherapy toxicity) and the effects of undertreatment (recurrent disease, increased mortality) [1, 2, 33] .
Pelvic and para-aortic lymphadenectomy is essential for surgical staging in patients with synchronous primary endometrial and ovarian cancers [1, 2, 31, 32] . It has diagnostic, therapeutic and prognostic value. It defines accurately the extent of disease and determines the prognosis of patients [1, 2] . Undoubtedly, pelvic and para-aortic lymphadenectomy is the only way to identify patients with stage III disease [1, 2, 31, 32] . However, the extension of pelvic and para-aortic lymph node dissection (more than 14 lymph nodes) is an independent risk factor for postoperative complications [1, 2, 29, 30, [34] [35] [36] Moreover in elderly patients and in patients with relevant comorbidities (obesity, diabetes, coronary artery disease), morbidity must be carefully weighed against any survival advantage [1,2,33,37,38].
The significance of postoperative adjuvant treatment in patients with synchronous primary endometrial and ovarian cancers, remains controversial [14, 15, 39] . However in most cases, postoperative adjuvant treatment should be individualized according to the risk of relapse of each primary cancer [2, 39, 40] Moreover, the treatment of one primary cancer does not compromise the treatment of the other primary cancer [2, 41] . Postoperative adjuvant radiotherapy includes: external pelvic radiotherapy and/or brachytherapy. It is the appropriate treatment for high risk primary endometrial cancer [1, 2, 29, 30] .
Postoperative adjuvant chemotherapy is the appropriate treatment for advanced stage primary endometrial and ovarian cancers [1,2 ,40] . The most active chemotherapeutic agents for those patients, are: taxanes, anthracyclines and platinum compounds [11, 15] .
Prognostic factors for synchronous primary endometrial and ovarian cancers are: age, stage of ovarian cancer, grade of endometrial cancer and adjuvant treatment [43] [44] [45] . Patients with synchronous primary endometrial and ovarian cancers have 5-year overall survival 85.9% and 10 year overall survival 80.3%.14 Patients with synchronous primary endometrial and ovarian cancers have better overall survival than patients with single primary ovarian or endometrial cancer [1, 2, 9, 39, 41, 43, 46] . Moreover, patients with synchronous primary endometrial and ovarian cancers endometrioid type have better overall survival than patients with non-endometrioid or mixed histologic types [1, 2, 9, 39, 43] .
The reason for the better overall survival of those patients, is not intuitively obvious [1, 2, 14] . Perhaps favorable prognosis related with the detection of patients at early stage and low grade disease [1] [2] [3] 6, [20] [21] [22] 25, 28, 46, 47] . Moreover, the influence of the postoperative adjuvant treatment needs to be further investigated [39] .
